Admission Date:  [**2114-11-5**]     Discharge Date:  [**2114-11-9**]  Date of Birth:   [**2049-2-1**]     Sex:  M  Service:  [**Doctor Last Name **]  HISTORY OF PRESENT ILLNESS:  The patient is a 65-year-old male with a history of chronic obstructive pulmonary disease, mitral valve replacement and atrial valve replacement with mechanical valves, hypertension, atrial fibrillation who was admitted to the Medical Intensive Care Unit on [**11-5**] for right lateral lower lobe pneumonia complicated by hypotension.
He complained of cough with green sputum times three weeks and received amoxicillin from [**10-19**] to [**10-29**], prescribed by his primary care physician without improvement, but did complain of occasional chest discomfort, loose bowel movements, and occasional shortness of breath.
At the Emergency Room of [**Hospital1 190**] he was found to have bilateral lower lobe pneumonia, was tachypneic with rates of 22 to 26 respirations per minute, and required supplemental oxygen via nasal cannula.
He suffered from systolic hypotension in the 90s and was fluid resuscitated with 3 liters of normal saline and required dopamine.
Dopamine was discontinued because of resulting tachycardia and he was changed to Neo-Synephrine via peripheral IV.
Pneumonia was treated with levofloxacin in the Emergency Room and changed to ceftriaxone plus azithromycin.
A femoral line was placed due to increased INR, and 2 units of fresh frozen plasma were administered.
He showed some evidence of mild prerenal azotemia which was treated with volume resuscitation.
Atrial fibrillation, status post conversion, on amiodarone.
Status post cholecystectomy with appendectomy.
Status post bilateral total knee replacement.
MEDICATIONS ON ADMISSION:  Medications on admission include Lasix 40 mg p.o.
q.d., Lopressor 25 mg p.o.
b.i.d., enalapril 20 mg p.o.
b.i.d., Coumadin 7.5 mg p.o.
q.p.m., Prilosec 40 mg p.o.
q.d., beclomethasone nasal spray, Atrovent 2 puffs q.i.d., Flovent 110 2 puffs b.i.d., [**Doctor First Name **] 60 mg p.o.
b.i.d., amiodarone 200 mg p.o.
Upon admission to the Medicine Service the patient was treated on levofloxacin 500 mg q.d., and ceftriaxone and azithromycin were discontinued.
The patient responded well to aggressive daily chest physical therapy as well.
The patient was to proceed with a 14-day course of levofloxacin 500 mg p.o.
He was maintained on a reduced dose of Lopressor at 12.5 mg p.o.
and a full dose of amiodarone 200 mg p.o.
The patient was maintained on a regimen of Coumadin 7.5 mg p.o.
Evaluation was begun during this admission including a workup for iron deficiency anemia with total iron binding capacity, iron, and reticulocyte counts pending, as well as an evaluation of potential dietary deficiency including B12 and folate levels.
AZOTEMIA:  The patient showed evidence of a prerenal azotemia throughout his stay which improved with fluid resuscitation.
The patient was begun on a modest regimen of antihypertensives including a reduced dose of Lopressor 12.5 mg p.o.
b.i.d., and his baseline dose of amiodarone 200 mg p.o.
The patient's home dose of enalapril was also reduced to 10 mg p.o.
Modifications in the patient's regimen for hypertension should be considered when the patient presents in two weeks to his primary care physician.
Levofloxacin 500 mg p.o.
Lopressor 12.5 mg p.o.
Amiodarone 200 mg p.o.
Coumadin 7.5 mg p.o.
Ambien 5 mg p.o.
Enalapril 10 mg p.o.
Status post atrial valve and mitral valve replacements.
Status post cholecystectomy and appendectomy.
Status post total knee replacement.
